Daniel Fahey

1 month ago | lockportjournal.com | Daniel Fahey

Measles, a virus once declared “eliminated” in the United States, is currently making headlines again — and not for good reasons. As confirmed cases increase at a rapid rate, it’s natural to wonder why the resurgence. The answer is simple: fewer people are getting vaccinated.

Mar 6, 2025 | natlawreview.com | Daniel Fahey

A new year brings about new legislation. Given the recent trend of health care transactions coming under increased scrutiny at the state level, EBG has released its map summarizing states that already have laws regulating health care transactions. As legislatures reconvene around the country, there continues to be regulatory scrutiny of health care transactions and private equity investment in health care. Below is a brief summary of recently proposed legislation.

Mar 6, 2025 | healthlawadvisor.com | Daniel Fahey |Timothy Murphy

A new year brings about new legislation. Given the recent trend of health care transactions coming under increased scrutiny at the state level, EBG has released its map summarizing states that already have laws regulating health care transactions. As legislatures reconvene around the country, there continues to be regulatory scrutiny of health care transactions and private equity investment in health care. Below is a brief summary of recently proposed legislation.

Mar 3, 2025 | natlawreview.com | Daniel Fahey

Skip to main content March 03, 2025 Volume XV, Number 62 Legal Analysis. Expertly Written. Quickly Found. Trending News Sitting Atop a Telehealth Cliff? Print Mail Download />i Facebook Twitter Linkedin Pinterest Reddit Facebook Messenger Email Digg Print X Buffer Flipboard Once again, Congress is quickly approaching a telehealth cliff.

Jan 21, 2025 | healthlawadvisor.com | Alan Arville |Audrey Davis |Daniel Fahey |Amy E. Lerman

Remote prescribing via telemedicine continues to be a huge area of interest among prescribers and other health care providers. After publishing a Notice of Proposed Rulemaking (“NPRM”) in March 2023 on the prescribing of controlled substances via telemedicine that was widely criticized for being far more restrictive than temporary waivers then in place under the COVID-19 public health emergency, the Drug Enforcement Administration (“DEA”) went back to the drawing board.